Related Articles

• Trabectedin in combination with pegylated liposomal doxorubicin in patients with ovarian tumors
• Phase II trial of doxil for patients with metastatic melanoma refractory to frontline therapy.
• Non‑pegylated liposomal doxorubicin for patients with recurrent ovarian cancer: A multicentric phase II trial
• Paclitaxel and liposomal doxorubicin (Caelyx) combination in advanced breast cancer patients: a Phase II study
• Topotecan plus ifosfamide in patients with platinum refractory advanced/metastatic non-small cell lung cancer: A phase II trial